Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Clin Cancer Res. 2014 Dec 2;21(7):1558–1565. doi: 10.1158/1078-0432.CCR-14-0595

Table 4.

Summary of Cycle 1 IMC-A12 Pharmacokinetic (PK) Parameters

IMC-A12 Dose
Temsirolimus Dose
6 mg/kg
8 mg/m2
(n=8)
6 mg/kg
10 mg/m2
(n = 3)
6 mg/kg
15 mg/m2
(n = 4)
Median Range Median Range Median Range
Cmax (μg/mL) 281 (239–355) 277 (219–390) 230 (161–464)
Tmax (h) 2.0 (1.0–7.0) 1.1 (1.1–2.2) 2.1 (1.1–7.0)
t1/2 (h) 98 (64–161) 122 (88–133) 130 (98–446)
AUC0–7d (h•μg/L) 20.6 (11.6–29.7) 25.6 (20.6–28.7) 26.4 (14.8–34.0)
CL (mL/h) 8.3 (1.1–15.2) 9.9 (2.9–14.5) 7.0 (3.1–14.3)
CL (mL/h/kg) 0.19 (0.12–0.43) 0.17 (0.12–0.18) 0.13 (0.07–0.24)
Vdss (mL) 1050 (150–2390) 1750 (470–1840) 1860 (590–2400)
Vdss (mL/kg) 25.8 (20.8–40.3) 22.7 (20.7–29.4) 31.1 (18.6–42.3)